StockData
Charles River Laboratories International, Inc. logo

Charles River Laboratories International, Inc. (CRL) stock

CRLNYSEServices-Commercial Physical & Biological ResearchFiscal year ends December 27
Financials through Q2 FY2026, quarter ended Jun 27, 2026Last filing: 10-Q on Nov 4, 2026Score 6/30225% above fair value
$332.16−3.36 (-1.00%)

Close on Nov 17, 2026Market cap $15.86BP/E –Yield –

Charles River Laboratories International enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Charles River Laboratories International's enterprise value was $18.66B on Nov 11, 2026, against $10.75B a year earlier. Over the last 5 years it ranged from $8.11B to $21.70B, with a median of $13.08B.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$18.66B+58.1%
2025Dec 31, 2025$11.80B+2.1%
2024Dec 31, 2024$11.56B-20.2%
2023Dec 29, 2023$14.49B+4.8%
2022Dec 30, 2022$13.83B-36.2%
2021Dec 31, 2021$21.70B+52.8%
2020Dec 31, 2020$14.20B+54.2%
2019Dec 31, 2019$9.21B+32.1%
2018Dec 31, 2018$6.97B+12.7%
2017Dec 29, 2017$6.19B+30.4%
2016Dec 30, 2016$4.74B+5.3%
2015Dec 31, 2015$4.50B+24.4%
2014Dec 31, 2014$3.62B-99.9%
2013Dec 31, 2013$2.56T+106683.4%
2012Dec 31, 2012$2.40B+19.1%
2011Dec 30, 2011$2.01B-23.4%
2010Dec 31, 2010$2.63B–

More Charles River Laboratories International figures

See a number that looks wrong?